# MiNK Therapeutics, Inc.: Form DEF 14A, filed Dec 20, 2024

- Company: [MiNK Therapeutics, Inc.](/companies/inkt.md) (CIK 1840229)
- Form: DEF 14A
- Filed: 2024-12-20
- Accepted by EDGAR: Dec 20, 2024, 21:17 ET
- Period: 2025-01-17
- Accession: 0001140361-24-050096
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1840229/000114036124050096/ny20039626x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1840229/000114036124050096/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1840229/000114036124050096/ny20039626x2_def14a.htm

Filed Dec 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-050096. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.